Join to View Full Profile
240 E 38th St# 18New York, NY 10016
Phone+1 646-501-7500
Fax+1 646-754-9593
Dr. Krupp is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I direct the MS division at NYU Langone, across LI, Brooklyn, NYC, and lead clinical research in MS across the age span with primarily investigator initiated studies. My interests focus on pediatric MS and other pediatric CNS demyelinating disorders and issues related to fatigue, cognitive function. More recent research addresses the effects of childhood adversity in pediatric and adult onset MS.
Education & Training
National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 1985 - 1987
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1982 - 1985
Westchester Medical CenterInternship, Internal Medicine, 1981 - 1982
Albert Einstein College of MedicineClass of 1981
Certifications & Licensure
NY State Medical License 1984 - 2028
MD State Medical License 1987 - 1988
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
Clinical Trials
- Improving Memory in Patients With Multiple Sclerosis Start of enrollment: 1999 Sep 01
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
- Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.Melissa A Wright, Bradley J Barney, Skyler Peterson, Michael Waltz, John Rose
Journal of Child Neurology. 2026-04-01 - 3 citationsReal-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis.Aaron W Abrams, Michael Waltz, T Charles Casper, Gregory Aaen, Leslie A Benson
Annals of Neurology. 2026-03-01 - Incorporating Measures of Cognitive Processing Speed and Brain Volume in Clinical Management of Pediatric Onset Multiple Sclerosis.Anna Sosa, Kimberly A O'Neill, Thibo Billiet, Jingyun Chen, Laura Couvreur
Pediatric Neurology. 2026-02-01
Journal Articles
- Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple SclerosisJerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine
Press Mentions
Multiple Sclerosis: Causes, Signs and TreatmentsMarch 10th, 2025- New MS Treatment Shows Promise in TrialAugust 25th, 2022
- The Pros and Cons of Remote Learning for MS KidsSeptember 21st, 2020
Grant Support
- Childhood Adversity Research Effort in Multiple Sclerosis (CARE.in.MS)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
